| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.00B | 9.45B | 9.49B | 10.11B | 9.39B | 7.84B |
| Gross Profit | 1.78B | 1.73B | 1.65B | 1.95B | 1.94B | 1.39B |
| EBITDA | 563.00M | 501.90M | 494.50M | 780.20M | 795.70M | 267.60M |
| Net Income | 223.50M | 131.30M | -35.40M | 196.40M | 250.00M | -220.50M |
Balance Sheet | ||||||
| Total Assets | 7.69B | 7.55B | 7.77B | 7.95B | 7.89B | 7.34B |
| Cash, Cash Equivalents and Short-Term Investments | 634.40M | 793.30M | 767.70M | 644.50M | 770.70M | 1.07B |
| Total Debt | 389.80M | 3.31B | 3.57B | 3.60B | 3.66B | 3.68B |
| Total Liabilities | 5.73B | 5.79B | 6.10B | 6.29B | 6.44B | 6.24B |
| Stockholders Equity | 1.96B | 1.75B | 1.68B | 1.66B | 1.45B | 1.09B |
Cash Flow | ||||||
| Free Cash Flow | 128.50M | 167.00M | 101.20M | -1.60M | 495.70M | -79.20M |
| Operating Cash Flow | 198.30M | 208.00M | 152.20M | 49.10M | 549.50M | -38.20M |
| Investing Cash Flow | -62.10M | 81.20M | 48.90M | -120.70M | -749.50M | -257.80M |
| Financing Cash Flow | -289.00M | -253.40M | -120.80M | -79.30M | -65.80M | 571.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $14.28B | 23.20 | 9.14% | ― | 12.51% | 32.34% | |
69 Neutral | $46.25B | 37.83 | 14.26% | ― | 14.61% | 30.19% | |
68 Neutral | $3.59B | 16.23 | 12.21% | ― | 6.77% | 150.72% | |
67 Neutral | $1.71B | ― | -8.09% | 2.06% | 5.08% | 41.21% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | $2.96B | 28.40 | 8.08% | 0.66% | 22.22% | 94.52% | |
56 Neutral | $1.15B | -92.57 | -1.09% | 1.72% | 20.74% | 78.92% |
Cushman & Wakefield’s recent earnings call showcased a strong financial performance, highlighted by record-breaking leasing revenues and significant debt reduction. The company reported robust growth in adjusted EPS and capital markets, although challenges were noted in APAC leasing revenue and earnings from equity method investments.
Cushman & Wakefield is a global leader in commercial real estate services, providing a range of services including leasing, capital markets, and valuation across 60 countries. The company is recognized for its award-winning culture and commitment to delivering top-tier advisory services.
On October 21, 2025, Cushman & Wakefield announced an amendment to its Credit Agreement, reducing revolving commitments from $1.1 billion to $1 billion and extending the maturity date to October 21, 2030. This move, which was oversubscribed, reflects lender confidence in the company’s financial strategy and aims to enhance capital efficiency and liquidity.
The most recent analyst rating on (CWK) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Cushman & Wakefield stock, see the CWK Stock Forecast page.
On October 16, 2025, Cushman & Wakefield shareholders approved the company’s plan to change its jurisdiction of incorporation from England and Wales to Bermuda. This decision was made during a series of shareholder meetings where various proposals, including the issuance of new shares and governance changes, were overwhelmingly supported. The redomiciliation is expected to reduce administrative burdens and costs while maintaining strong corporate governance and capital flexibility. The company plans to finalize the redomiciliation by November 27, 2025, subject to legal and regulatory procedures.
The most recent analyst rating on (CWK) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Cushman & Wakefield stock, see the CWK Stock Forecast page.
On October 2, 2025, Cushman & Wakefield announced the successful repricing of its $840 million Term Loan, reducing the interest rate by 25 basis points. This move, part of the company’s strategy for debt reduction and disciplined growth, reflects strong momentum and lender support, having already prepaid $200 million of its Term Loan in 2025.
The most recent analyst rating on (CWK) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Cushman & Wakefield stock, see the CWK Stock Forecast page.
Cushman & Wakefield faces significant uncertainty regarding the completion and potential benefits of its Proposed Redomicile, as the process hinges on obtaining various shareholder and court approvals. The indefinite adjournment of a key shareholder meeting and withdrawal of resolutions indicate challenges in securing the necessary support, prompting further engagement with shareholders. This delay not only risks negative market reactions and potential impacts on share price but also diverts management attention, potentially undermining the anticipated advantages of the redomicile. Even if completed, there is no guarantee that the company will realize the expected benefits, posing a substantial risk to its strategic objectives.
Cushman & Wakefield is a global leader in commercial real estate services, offering expertise in property management, leasing, capital markets, and valuation across 60 countries. The company reported robust financial results for the second quarter of 2025, showcasing a 9% increase in revenue to $2.5 billion and a significant rise in net income to $57.3 million, compared to the same period last year. Key highlights include a 27% growth in capital markets revenue, driven by strong performance in the Americas, and an 8% increase in leasing revenue. Additionally, the company made a strategic move by announcing a $150 million debt repayment, reflecting its focus on strengthening the balance sheet. Cushman & Wakefield’s strategic initiatives and cost-saving measures have resulted in a 16% increase in adjusted EBITDA, reaching $161.7 million. The company continues to benefit from its expanded recruiting efforts and market positioning, which have contributed to its sustained growth. Looking forward, Cushman & Wakefield remains optimistic about its future prospects, with a commitment to delivering value to its stakeholders through strategic growth and operational excellence.
Cushman & Wakefield’s recent earnings call painted a picture of robust financial health and strategic growth. The sentiment was overwhelmingly positive, driven by significant EPS and revenue growth, effective debt reduction strategies, and impressive client retention rates. Despite facing some challenges in the APAC region and a decrease in equity investments, the company’s strategic expansions in capital markets and leasing underscore a positive trajectory.